» Articles » PMID: 17360943

Lipoprotein Metabolism and Lipid Management in Chronic Kidney Disease

Overview
Specialty Nephrology
Date 2007 Mar 16
PMID 17360943
Citations 118
Authors
Affiliations
Soon will be listed here.
Citing Articles

Lipidomics-based natural products for chronic kidney disease treatment.

Zhang R, Wang J, Wu C, Wang L, Liu P, Li P Heliyon. 2025; 11(1):e41620.

PMID: 39866478 PMC: 11758422. DOI: 10.1016/j.heliyon.2024.e41620.


Analysis of changes in PCSK9 and TNF-α concentrations in response to physical exercises using virtual reality in patients in the fifth stage of chronic kidney disease undergoing hemodialysis.

Turon-Skrzypinska A, Minko A, Ryl A, Cymbaluk-Ploska A, Domanski M, Ciechanowski K BMC Nephrol. 2025; 26(1):1.

PMID: 39743553 PMC: 11694471. DOI: 10.1186/s12882-024-03917-z.


Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications.

Siracusa C, Carabetta N, Morano M, Manica M, Strangio A, Sabatino J Int J Mol Sci. 2024; 25(23).

PMID: 39684805 PMC: 11642360. DOI: 10.3390/ijms252313096.


Caspase-4/11 promotes hyperlipidemia and chronic kidney disease-accelerated vascular inflammation by enhancing trained immunity.

Sun Y, Lu Y, Liu L, Saaoud F, Shao Y, Xu K JCI Insight. 2024; 9(16).

PMID: 39024553 PMC: 11343595. DOI: 10.1172/jci.insight.177229.


Extracellular vesicles and lipoproteins - Smart messengers of blood cells in the circulation.

Nguyen P, Le A, Pek J, Pham T, Jayasinghe M, Do D J Extracell Biol. 2024; 1(7):e49.

PMID: 38938581 PMC: 11080875. DOI: 10.1002/jex2.49.